BECancerResistome is a project leveraging CRISPR base editing to systematically identify mutations associated with drug resistance in cancer. This project aims to unravel the genetic basis of resistance mechanisms by screening cancer cell lines under various drug treatments.
Instituto Superior Técnico (U Lisboa) and The Broad Insitute of MIT and Harvard.
This project is licensed under the BSD 3-Clause "New" or "Revised" License. See the LICENSE file for details.